Abstract

AeroVironment will announce quarterly financial results on September 9, 2026, Post-Mkt; this preview compiles the latest consensus forecasts, the prior quarter’s actuals, business mix, and recent analyst views to frame the near-term earnings setup and the key issues likely to drive the stock’s reaction.

Market Forecast

Consensus for the upcoming quarter points to revenue of 458.55 million US dollars, up 4.34% year over year, with adjusted EPS near 0.28, implying a 23.30% year-over-year decline; estimates also imply EBIT of negative 28.03 million US dollars, down 226.27% year over year. Forecast gross profit margin and net profit margin were not provided; if disclosed with results, margin trajectory versus the prior quarter will be a core focus alongside the magnitude of any non-cash items.

Within operations, the delivery cadence of autonomous systems and precision-strike platforms remains the central swing factor for the near-term top line and mix. For growth leverage beyond the quarter, the counter‑UAS and directed‑energy pipeline cited by several research notes, as well as multi‑year IDIQ awards discussed recently, provide additional visibility, though the timing of revenue conversion remains the primary unknown heading into the print.

Last Quarter Review

AeroVironment reported revenue of 641.62 million US dollars, a gross profit margin of 31.58%, a GAAP net loss attributable to shareholders of 24.10 million US dollars (net profit margin of -3.76%), and adjusted EPS of 1.84, up 14.29% year over year; top line grew 133.27% year over year on stronger deliveries. A notable financial highlight was EBIT of 56.94 million US dollars, up 312.11% year over year and ahead of expectations by 13.80 million US dollars.

From a business-mix standpoint, autonomous systems delivered approximately 492.00 million US dollars in the quarter, with precision‑strike platforms highlighted as the leading driver, and the overall company revenue advanced 133.27% year over year. Based on reported mix, Products accounted for roughly 71.60% (about 1.42 billion US dollars) and Contract Services 28.40% (about 0.56 billion US dollars), reinforcing that hardware-driven shipments dominated the revenue base while services continued to provide recurring and program support revenue.

Current Quarter Outlook

Main business delivery and mix

Execution hinges on how quickly funded backlog converts into shipments and revenue recognition this quarter. Management most recently pointed to funded backlog around 1.20 billion US dollars, and the prior quarter’s performance demonstrated that manufacturing throughput and supply‑chain coordination can move the needle meaningfully on quarterly revenue. The expected 4.34% year‑over‑year revenue increase implies a normalization from last quarter’s surge, consistent with the pattern of programs that ship in batches and with delivery timing sometimes clustering at quarter-end.

Mix will matter for margins. Last quarter’s gross margin of 31.58% reflected the interplay between volume leverage, program mix, and integration effects from recent acquisitions; the consensus EBIT swing to a negative 28.03 million US dollars suggests the Street is braced for heavier non‑cash or one‑off items and a less favorable mix in the near term. If the shipment slate this quarter tilts toward earlier‑phase programs, test assets, or lower‑margin configurations, reported gross margin could compress sequentially even if revenue meets the top‑line estimate. Conversely, any upside in precision‑strike and small‑UAS production lots with stable material costs would provide a route to better‑than‑modeled margin resilience.

Working capital dynamics are another near‑term watch item. The last quarter’s double‑beat in revenue and adjusted EPS came with high fulfillment intensity; sustaining that pace usually requires careful management of long‑lead components and subassemblies. Any incremental build in inventory to support second‑half deliveries could weigh on free cash flow in the quarter, with positive implications for subsequent revenue conversion if the supply chain remains stable. The balance between shipment phasing, materials timing, and milestone billing will likely drive both intra‑quarter volatility and the quality of earnings.

Precision‑strike and counter‑UAS traction

Precision‑strike platforms led growth last quarter and are again positioned to be the most sensitive driver of upside or downside versus consensus. The recent program commentary across research notes points to multi‑year demand, while the company’s latest quarter confirmed that this portfolio can scale rapidly when supply and contract timing align. In the upcoming quarter, order conversion and end‑user acceptance under ongoing production lots will shape whether adjusted EPS can outperform the 0.28 estimate, especially if unit yields, rework rates, and vendor delivery performance hold at improved levels.

On counter‑UAS and directed‑energy, multiple analyst updates have highlighted a strong pipeline and referenced large IDIQ frameworks that can support deliveries across several quarters. While those awards typically ramp gradually rather than all at once, even modest shipment starts this quarter could help offset any softness in other programs and support revenue continuity into the next period. The strategic value of these awards is that they diversify the revenue base across different mission profiles and procurement channels, providing more levers to defend the gross margin line as product and service mixes evolve.

Taken together, the precision‑strike and counter‑UAS families provide the most credible route for sustained growth and medium‑term margin expansion. However, the near‑term EBIT consensus of negative 28.03 million US dollars underscores two considerations for this quarter: potential timing of non‑cash amortization linked to recent acquisitions and the possibility of conservative revenue recognition on early‑phase deliveries. If either of those factors is lighter than modeled, the stock could respond positively to better‑than‑expected profitability metrics even without a large revenue beat.

Key stock‑price drivers this quarter

The first catalyst is the reconciliation of GAAP versus adjusted results. Last quarter featured a GAAP net loss attributable to shareholders of 24.10 million US dollars alongside a 1.84 adjusted EPS print. The Street’s negative EBIT expectation implies concern that non‑cash items, acquisition‑related amortization, or residual impairment effects could again cloud GAAP comparability. Clarity on the durability of adjusted margins, the cadence of amortization, and any updates to purchase accounting fair‑value step‑ups will likely influence how investors extrapolate the run‑rate into the second half.

The second is backlog quality and schedule integrity. Commentary around funded backlog near 1.20 billion US dollars has supported the long‑dated demand narrative. For this quarter’s print, investors will look for evidence that recent program awards are translating into firm delivery schedules and that supply chain constraints are not pushing material shipments into later periods. Concrete data on throughput increases, supplier on‑time performance, and test throughput can reduce perceived timing risk and improve confidence in the revenue trajectory implied by guidance.

The third is program and governance overhangs. Recent headlines included a restated quarterly report with a goodwill impairment adjustment and an identified control weakness related to impairment analysis. While these items are non‑operational, investors will monitor management’s remediation steps and any incremental disclosures about the affected reporting unit. Similarly, developments tied to previously cited satellite‑communications program changes and related work scopes remain a sentiment variable. Management’s ability to demonstrate that the core portfolio is delivering to plan while non‑core exposure is ring‑fenced will shape the stock’s post‑print reaction.

Analyst Opinions

The majority of recent institutional commentary is constructive, with multiple firms reiterating Buy ratings and highlighting a favorable multi‑quarter delivery setup. Piper Sandler maintained a Buy rating with a 248.00 US dollars price target around the last report, pointing to upside potential from continued backlog conversion and program execution. Needham reiterated Buy with a 400.00 US dollars target, emphasizing that the revenue pipeline and shipment tempo support above‑trend growth even as GAAP results reflect acquisition‑related amortization. William Blair has repeatedly affirmed Buy in recent notes, underscoring the breadth of awarded work and calling out emerging opportunities in counter‑UAS and directed energy that should sustain the top‑line trajectory. Clear Street also maintained Buy with a 247.00 US dollars target, signaling confidence in backlog monetization and the longer‑term earnings path.

Balanced against these upbeat views, there are cautious voices centered on valuation sensitivity to margin ramp and program risks, including a recent downgrade to Sector Perform by one major broker and target cuts from another. However, the tally of published opinions over the last several months skews clearly positive, and the bullish camp remains the majority. The bullish argument rests on three pillars heading into the quarter: first, a delivery schedule that, while lumpy, is increasingly supported by firm backlog and production throughput; second, a portfolio where precision‑strike and counter‑UAS programs can deliver incremental revenue without requiring extraordinary cost growth; and third, a path to adjusted margin stabilization as integration effects and one‑time items fade, even if GAAP results remain noisy in the short run.

For the quarter at hand, these analysts will look for confirmation in three areas: revenue near or modestly above the 458.55 million US dollars consensus with a clear explanation of second‑half shipment phasing; an adjusted EPS print that narrows or exceeds the modeled 0.28 despite the Street’s negative EBIT assumption; and qualitative color that de‑risks backlog schedules and addresses governance remediation progress. Positive evidence on those points would support the majority Buy case that the company remains on track to translate multi‑year program momentum into consistent earnings power, even with quarter‑to‑quarter variability in GAAP margins.